Key facts
- Circle Safe’s last known valuation is $13.9M (Jan 2025).
- It has raised $8.3M; the latest was Accelerator/Incubator in Feb 2025.
- Notable investors include Bpifrance, Région Sud Investissement, Odyssee Venture, La French Tech Aix-Marseille Région Sud, Marseille Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Circle Safe
- ·The full record, as it builds
Funding rounds
No funding rounds for Circle Safe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Circle Safe
Developer of a medical device intended to prevent a specific complication during cardiac ablation procedures. The company offers a technology designed to eliminate the risk of diaphragmatic paralysis caused by cryoballoon ablation and PFA, addressing a key safety concern associated with these procedures, enabling electrophysiologists to perform ablation procedures with increased safety and confidence, thus potentially improving patient outcomes and broadening the adoption of this technique for treating atrial fibrillation.
- Sector
- Healthcare
- HQ
- Aubagne, France
- Founded
- 2020
- Employees
- 4
- Website
- circle-safe.com/
- Ownership
- Privately Held (backing)
Circle Safe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Circle Safe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Circle Safe in its N-PORT filings yet. We sweep new filings monthly.